NCT00572169 2026-02-05
UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
University of Arkansas
Phase 3 Active not recruiting
Clinical Trials
30 trialsNCT00734877 2025-06-29
TT4B
University of Arkansas
Phase 3 Active not recruiting
NCT06017284 2023-11-24
PTCA199-5
Fudan University
Phase 3 Recruiting
NCT02085655 2021-03-15
PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma
Sun Yat-sen University
Phase 3 Unknown
NCT00038233 2018-10-31
Thalidomide for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00232934 2018-08-02
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
Gruppo Italiano per lo Studio del Mieloma Multiplo
Phase 3 Completed
NCT03562169 2018-06-19
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
University of Leeds
Phase 3 Recruiting
NCT01554852 2018-06-11
Myeloma XI
University of Leeds
Phase 3 Unknown
NCT02248428 2017-09-06
CTd
Jinling Hospital, China
Phase 3 Unknown
NCT03016000 2017-07-28
Thalidomide Maintenance Treatment in DLBCL
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT02203253 2016-08-24
Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting
China Medical University, China
Phase 3 Completed
NCT02748772 2016-04-22
Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical
The First People's Hospital of Hefei
Phase 3 Unknown
NCT00083551 2015-11-23
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
University of Arkansas
Phase 3 Completed
NCT01971658 2015-10-07
IFM2013-04
Nantes University Hospital
Phase 3 Completed
NCT00111748 2015-10-06
UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients
University of Arkansas
Phase 3 Completed
NCT00215943 2014-04-17
Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)
H. Lee Moffitt Cancer Center and Research Institute
Phase 3 Terminated
NCT00218855 2014-03-07
Thalidomide to Patients With Previously Untreated Multiple Myeloma
Norwegian University of Science and Technology
Phase 3 Completed
NCT01134484 2012-07-20
VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 3 Unknown
NCT00432458 2012-07-04
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Mayo Clinic
Phase 3 Completed
NCT00061919 2012-03-16
Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
University College, London
Phase 3 Completed
NCT00443235 2011-09-19
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
PETHEMA Foundation
Phase 3 Completed
NCT00573391 2011-08-12
Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
University of Arkansas
Phase 3 Terminated
NCT00921531 2011-04-19
Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma
Fudan University
Phase 3 Unknown
NCT00602511 2011-02-09
Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma
Nordic Myeloma Study Group
Phase 3 Completed
NCT00083876 2010-07-02
D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
University of Arkansas
Phase 3 Completed
NCT01070862 2010-02-18
MAG 2002
University Hospital, Caen
Phase 3 Completed
NCT00461747 2009-09-18
GEM05MENOS65
PETHEMA Foundation
Phase 3 Completed
NCT00644306 2008-03-26
IFM 01/01
Central Hospital, Nancy, France
Phase 3 Terminated
NCT00633542 2008-03-12
Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)
Università Politecnica delle Marche
Phase 3 Completed
NCT00367185 2006-08-22
Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma
University Hospital, Lille
Phase 3 Completed